Pro-Dex Stock News

A Organiza

Se trata de una medicina barata que ayuda a la recuperación de pacientes graves o críticos

McAfee himself was clear in his social media posts that this Ghost exchange well stands to replace his former DEX, the McAfeeDEX.

Segundo Tedros Adhanom Ghebreyesus, diretor-geral da entidade, o primeiro milhão de casos levou três meses para ser atingido. Já o último milhão de casos aconteceu em apenas oito dias. Mundo teve

Tron is one of the major and popular blockchain-based systems in the industry that have backed up their existence with a digital asset.

Two Sigma Advisers LP increased its stake in shares of Rexnord Corp (NYSE:RXN) by 22.7% during the 1st quarter, Holdings Channel.com reports. The fund owned 376,127 shares of the industrial products c

In the last 24 hours, Curve Finance saw more volume than any other decentralized exchange (DEX) thanks to the latest yield farming trend.

WordPress sites are embracing the crypto age, and it appears that it’s getting more lucrative for them as well. Months after launching a WordPress plug-in to allow blog and web administrators to ad

Geode Capital Management LLC boosted its stake in Rexnord Corp (NYSE:RXN) by 4.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm

La actuación de la organización internacional en los últimos meses dista mucho del papel histórico que ha desarrollado en la lucha contra la polio o el SIDA

Bancor Network has discovered a vulnerability in its latest smart contract update, which may have caused a loss of user funds.  BNT tokens worth

Lower bitcoin spot volumes and flatter-than-usual price action doesn’t mean crypto traders have zero opportunities to capitalize.

New malicious Android apps were recently discovered and deleted from the Google Play Store.

Today’s cryptocurrency exchange scene is dominated by a small number of industry heavyweights, many of which have been breached in the past, or lack industry-leading features, but still continue to

Gilead Sciences has said it will start trials soon of its antiviral drug remdesivir in children – from